New Antibody Treatment for Tau-Related Brain Diseases
Immunotherapy Targeting Tau Aggregate Polymorphs
This project is developing special antibodies to clear harmful tau proteins that build up in the brains of people with Alzheimer's and similar conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Med Br Galveston NIH-funded |
| Lab location | 1 site (Galveston, United States) |
| Project ID | NIH-11297281 on NIH RePORTER |
What this research studies
Many brain diseases, like Alzheimer's, are linked to a protein called tau that clumps together in harmful ways. Our team has created unique antibodies, called TOMA clones, designed to specifically find and remove these toxic tau clumps, known as oligomers. We believe these tau clumps come in different forms, and this work will help us understand how effective our antibodies are against these various forms. The goal is to develop a new way to treat these devastating brain conditions by targeting the root cause of tau buildup.
Who could benefit from this research
Good fit: This foundational work is for individuals interested in the development of future treatments for Alzheimer's disease, frontotemporal lobar degeneration, and other tauopathies.
Not a fit: Patients seeking immediate treatment options would not directly benefit from this early-stage laboratory research.
Why it matters
Potential benefit: If successful, this work could lead to new antibody-based treatments that slow or stop the progression of Alzheimer's disease and other related brain conditions.
How similar studies have performed: While other groups are exploring tau-targeting therapies, this project uses novel antibodies specifically designed to recognize different forms of toxic tau oligomers, building on promising results in animal models.
Where this research is happening
Galveston, United States
- University of Texas Med Br Galveston — Galveston, United States (Active)
Researchers
- Principal investigator: Kayed, Rakez — University of Texas Med Br Galveston
- Study coordinator: Kayed, Rakez
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.